Yongmeng Li

419 total citations
19 papers, 256 citations indexed

About

Yongmeng Li is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Yongmeng Li has authored 19 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Yongmeng Li's work include RNA modifications and cancer (5 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). Yongmeng Li is often cited by papers focused on RNA modifications and cancer (5 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). Yongmeng Li collaborates with scholars based in China, Greece and Japan. Yongmeng Li's co-authors include Hui Tian, Jin Jiang, Renchang Zhao, Jingyi Han, Jinghui Liang, Xuebing Li, Yufang Ma, Yan Zhou, Jiang Wang and Zhenguo Sun and has published in prestigious journals such as Scientific Reports, Journal of Clinical Pathology and Clinica Chimica Acta.

In The Last Decade

Yongmeng Li

18 papers receiving 254 citations

Peers

Yongmeng Li

PRM

ONCOL

IMMUN

Giulia Brisotto Italy

Yanzhao Xu China

Aarif Siddiqui Germany

Martina Godel Italy

Hongjuan Cui China

Tristan M. G. Kenney Canada

О. А. Степанов Russia

Emma Cattell United Kingdom

Christina Kalderén Sweden

Saima Usman United Kingdom

Giulia Brisotto Italy

Yongmeng Li

217 ×1.2

162 ×1.8

38 ×0.7

PRM

87 ×2.1

ONCOL

17 ×0.7

IMMUN

Citations per year, relative to Yongmeng Li Yongmeng Li (= 1×) peers Giulia Brisotto

Countries citing papers authored by Yongmeng Li

Since Specialization

Citations

This map shows the geographic impact of Yongmeng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongmeng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongmeng Li more than expected).

Fields of papers citing papers by Yongmeng Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongmeng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongmeng Li. The network helps show where Yongmeng Li may publish in the future.

Co-authorship network of co-authors of Yongmeng Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yongmeng Li. A scholar is included among the top collaborators of Yongmeng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongmeng Li. Yongmeng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Li, Yongmeng, Xiaodong Chai, Ming Yang, et al.. (2025). Accurate prediction of disease-free and overall survival in non-small cell lung cancer using patient-level multimodal weakly supervised learning. npj Precision Oncology. 9(1). 197–197. 1 indexed citations

Zhang, Zhan, Yue Zhao, Yuanyuan Ma, et al.. (2025). Prediction of STAS in lung adenocarcinoma with nodules ≤ 2 cm using machine learning: a multicenter retrospective study. BMC Cancer. 25(1). 417–417. 3 indexed citations

Chai, Xiaodong, Junfeng Zeng, Yongmeng Li, et al.. (2025). Multimodal prediction of tyrosine kinase inhibitors therapy outcomes in advanced EGFR-mutated NSCLC patients. Journal of Translational Medicine. 23(1). 933–933. 1 indexed citations

Zhang, Zhan, Junjie Liu, Yue Zhao, et al.. (2024). Nomograms to predict tumor regression grade (TRG) and ypTNM staging in patients with locally advanced esophageal cancer receiving neoadjuvant therapy. World Journal of Surgical Oncology. 22(1). 198–198.

Li, Yongmeng, et al.. (2024). BZW2 promotes malignant progression in lung adenocarcinoma through enhancing the ubiquitination and degradation of GSK3β. Cell Death Discovery. 10(1). 105–105. 5 indexed citations

Wang, Shuai, et al.. (2024). PSME3 promotes lung adenocarcinoma development by regulating the TGF-β/SMAD signaling pathway. Translational Lung Cancer Research. 13(6). 1331–1345. 2 indexed citations

Zhang, Nana, Yongmeng Li, Lijuan Zhou, et al.. (2024). Combined detection of SHOX2 and PTGER4 methylation with serum marker CYFRA21-1 for improved diagnosis of malignant pleural mesothelioma. Journal of Clinical Pathology. 78(12). 836–842. 1 indexed citations

Zhang, Nana, Yongmeng Li, Yujie Dong, et al.. (2023). Performance of SHOX2 and RASSF1A methylation assay in supernatants and matched cell pellets for the diagnosis of malignant pleural effusion. Clinica Chimica Acta. 553. 117699–117699. 2 indexed citations

Yu, Wenhao, Tao Fang, Yongmeng Li, et al.. (2023). Cyclin O promotes lung cancer progression and cetuximab resistance via cell cycle regulation and CDK13 interaction. Journal of Thoracic Disease. 15(4). 2167–2183. 1 indexed citations

10.

Li, Yongmeng, et al.. (2023). UHMK1 promotes lung adenocarcinoma oncogenesis by regulating the PI3K/AKT/mTOR signaling pathway. Thoracic Cancer. 14(12). 1077–1088. 3 indexed citations

11.

Li, Yongmeng, Rui Dong, Ming Lü, et al.. (2021). Let-7b-3p inhibits tumor growth and metastasis by targeting the BRF2-mediated MAPK/ERK pathway in human lung adenocarcinoma. Translational Lung Cancer Research. 10(4). 1841–1856. 23 indexed citations

12.

Li, Yongmeng, Yanfei Liu, Cun Gao, et al.. (2021). Negatively Regulated by miR-29c-3p, MTFR1 Promotes the Progression and Glycolysis in Lung Adenocarcinoma via the AMPK/mTOR Signalling Pathway. Frontiers in Cell and Developmental Biology. 9. 771824–771824. 14 indexed citations

13.

Yue, Weiming, Lin Li, Shuhai Li, et al.. (2021). Circular RNA hsa-circ-000881 suppresses the progression of lung adenocarcinoma in vitro via a miR-665/PRICKLE2 axis. Annals of Translational Medicine. 9(6). 498–498. 10 indexed citations

14.

Gao, Cun, et al.. (2021). MCTS1 promotes the development of lung adenocarcinoma by regulating E2F1 expression. Oncology Letters. 22(1). 531–531. 7 indexed citations

15.

Liu, Xiao, Jinghui Liang, Yongmeng Li, et al.. (2021). Integrated bioinformatics analysis of differentially expressed genes and immune cell infiltration characteristics in Esophageal Squamous cell carcinoma. Scientific Reports. 11(1). 16696–16696. 19 indexed citations

16.

Wang, Jiang, et al.. (2021). Oncogenic role of abnormal spindle‑like microcephaly‑associated protein in lung adenocarcinoma. International Journal of Oncology. 58(5). 11 indexed citations

17.

Liang, Jinghui, Jingyi Han, Jin Jiang, et al.. (2020). Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway. Cell Death and Disease. 11(8). 614–614. 102 indexed citations

18.

Li, Yongmeng, et al.. (2019). Stereocomplex micelle loaded with paclitaxel for enhanced therapy of breast cancer in an orthotopic mouse model. Journal of Biomaterials Science Polymer Edition. 30(3). 233–246. 9 indexed citations

19.

Li, Yongmeng, Yan Zhou, Yufang Ma, & Xuebing Li. (2011). Design and synthesis of novel cell wall inhibitors of Mycobacterium tuberculosis GlmM and GlmU. Carbohydrate Research. 346(13). 1714–1720. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact